Aurinia Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies to treat autoimmune and rare diseases

The company is dedicated to advancing its pipelines, particularly in developing treatments for conditions such as lupus nephritis, with a commitment to improving patient outcomes through scientifically driven solutions. Aurinia’s goal is to bring forward novel medications that address unmet medical needs and transform the standard of care in its therapeutic areas.